Tilray Brands Inc (TLRY)
1.845
+0.12
(+6.65%)
USD |
NASDAQ |
Apr 23, 16:00
1.83
-0.02
(-0.81%)
After-Hours: 20:00
Tilray Brands Cash from Financing (TTM): -76.02M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -76.02M |
November 30, 2023 | -67.55M |
August 31, 2023 | -39.44M |
May 31, 2023 | 70.16M |
February 28, 2023 | 225.73M |
November 30, 2022 | 222.61M |
August 31, 2022 | 259.84M |
May 31, 2022 | 128.20M |
February 28, 2022 | -96.49M |
November 30, 2021 | -9.677M |
August 31, 2021 | 109.54M |
May 31, 2021 | 124.31M |
February 28, 2021 | 182.92M |
November 30, 2020 | 175.12M |
August 31, 2020 | 139.29M |
May 31, 2020 | 130.61M |
February 29, 2020 | 470.22M |
November 30, 2019 | 401.42M |
August 31, 2019 | 334.86M |
May 31, 2019 | 547.18M |
February 28, 2019 | 206.58M |
November 30, 2018 | 299.16M |
August 31, 2018 | 369.88M |
May 31, 2018 | 160.02M |
Date | Value |
---|---|
February 28, 2018 | 242.46M |
November 30, 2017 | 188.38M |
August 31, 2017 | 160.25M |
May 31, 2017 | 193.10M |
February 28, 2017 | 120.81M |
November 30, 2016 | 85.29M |
August 31, 2016 | 45.84M |
May 31, 2016 | 12.56M |
February 29, 2016 | |
November 30, 2015 | |
August 31, 2015 | |
May 31, 2015 | |
February 28, 2015 | |
November 30, 2014 | |
August 31, 2014 | |
May 31, 2014 | |
February 28, 2014 | |
November 30, 2013 | |
August 31, 2013 | |
May 31, 2013 | |
February 28, 2013 | |
November 30, 2012 | |
August 31, 2012 | 0.304M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-96.49M
Minimum
Feb 2022
547.18M
Maximum
May 2019
161.64M
Average
134.95M
Median
Cash from Financing (TTM) Benchmarks
Clever Leaves Holdings Inc | 0.656M |
Flora Growth Corp | 3.15M |
Acasti Pharma Inc | 7.359M |
Aurinia Pharmaceuticals Inc | -5.13M |
Edesa Biotech Inc | 2.224M |